Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Ohashi

Showing results (671-680 of 703) with videos related to

Pageof 71
Sort By:
Oncology|January 25, 2000
Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancerT Sugiyama, M Yakushiji, K Noda, et al.
Plant & Cell Physiology|January 1, 1996
Efficient promoter cassettes for enhanced expression of foreign genes in dicotyledonous and monocotyledonous plantsI Mitsuhara, M Ugaki, H Hirochika, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 20, 2012
Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors--phase I trial: 2nd reportA Shirahata, K Fukutake, J Mimaya, et al.
Plant Cell Reports|February 14, 2019
Agrobacterium-mediated transformation of monocot and dicot plants using the NCR promoter derived from soybean chlorotic mottle virusH Fukuoka, T Ogawa, I Mitsuhara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 4, 2001
[Comparison of management of advanced cancer in various organs]H Akaza, T Saeki, K Kawai, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 4, 2011
Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors--phase I trialA Shirahata, K Fukutake, J Mimaya, et al.
Neurology|June 24, 2004
A new diagnostic test for VLCAD deficiency using immunohistochemistryY Ohashi, Y Hasegawa, K Murayama, et al.
Journal of Immunological Methods|January 17, 2002
Flow cytometric determination of intracytoplasmic Wiskott-Aldrich syndrome protein in peripheral blood lymphocyte subpopulationsS Kawai, M Minegishi, Y Ohashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 2001
[Platinum compounds in cancer therapy--past, present, and future]H Akaza, N Saijo, K Aiba, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II studyT Igarashi, Y Kobayashi, M Ogura, et al.
Pageof 71

Showing results (671-680 of 703) with videos related to

Sort By:
Pageof 71
Oncology|January 25, 2000
Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancerT Sugiyama, M Yakushiji, K Noda, et al.
Plant & Cell Physiology|January 1, 1996
Efficient promoter cassettes for enhanced expression of foreign genes in dicotyledonous and monocotyledonous plantsI Mitsuhara, M Ugaki, H Hirochika, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 20, 2012
Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors--phase I trial: 2nd reportA Shirahata, K Fukutake, J Mimaya, et al.
Plant Cell Reports|February 14, 2019
Agrobacterium-mediated transformation of monocot and dicot plants using the NCR promoter derived from soybean chlorotic mottle virusH Fukuoka, T Ogawa, I Mitsuhara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 4, 2001
[Comparison of management of advanced cancer in various organs]H Akaza, T Saeki, K Kawai, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 4, 2011
Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors--phase I trialA Shirahata, K Fukutake, J Mimaya, et al.
Neurology|June 24, 2004
A new diagnostic test for VLCAD deficiency using immunohistochemistryY Ohashi, Y Hasegawa, K Murayama, et al.
Journal of Immunological Methods|January 17, 2002
Flow cytometric determination of intracytoplasmic Wiskott-Aldrich syndrome protein in peripheral blood lymphocyte subpopulationsS Kawai, M Minegishi, Y Ohashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 2001
[Platinum compounds in cancer therapy--past, present, and future]H Akaza, N Saijo, K Aiba, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II studyT Igarashi, Y Kobayashi, M Ogura, et al.
Pageof 71